A detailed history of Assetmark, Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Assetmark, Inc holds 204,071 shares of VRTX stock, worth $82.7 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
204,071
Previous 380,354 46.35%
Holding current value
$82.7 Million
Previous $178 Million 46.76%
% of portfolio
0.27%
Previous 0.56%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$460.0 - $505.78 $81.1 Million - $89.2 Million
-176,283 Reduced 46.35%
204,071 $94.9 Million
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $827,650 - $1.02 Million
-2,107 Reduced 0.55%
380,354 $178 Million
Q1 2024

May 06, 2024

SELL
$407.69 - $446.08 $2.01 Million - $2.2 Million
-4,937 Reduced 1.27%
382,461 $160 Million
Q4 2023

Feb 09, 2024

SELL
$343.0 - $410.68 $40.1 Million - $48.1 Million
-117,030 Reduced 23.2%
387,398 $158 Million
Q3 2023

Oct 27, 2023

SELL
$338.18 - $362.46 $2.28 Million - $2.44 Million
-6,743 Reduced 1.32%
504,428 $175 Million
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $8.7 Million - $9.74 Million
-27,668 Reduced 5.13%
511,171 $180 Million
Q1 2023

May 05, 2023

BUY
$283.23 - $323.1 $38.8 Million - $44.3 Million
137,127 Added 34.14%
538,839 $170 Million
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $3.96 Million - $4.45 Million
13,854 Added 3.57%
401,712 $116 Million
Q3 2022

Nov 01, 2022

BUY
$273.83 - $305.53 $104 Million - $116 Million
380,279 Added 5017.54%
387,858 $112 Million
Q2 2022

Aug 03, 2022

BUY
$234.96 - $292.55 $633,452 - $788,714
2,696 Added 55.21%
7,579 $2.14 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $677,988 - $799,090
3,062 Added 168.15%
4,883 $1.27 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $303,041 - $382,546
1,712 Added 1570.64%
1,821 $400,000
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $7,074 - $7,916
-39 Reduced 26.35%
109 $20,000
Q2 2021

Aug 16, 2021

SELL
$187.49 - $221.1 $3,562 - $4,200
-19 Reduced 11.38%
148 $30,000
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $7,038 - $8,204
34 Added 25.56%
167 $36,000
Q4 2020

Feb 10, 2021

SELL
$207.01 - $276.09 $4,554 - $6,073
-22 Reduced 14.19%
133 $31,000
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $39,370 - $46,677
-154 Reduced 49.84%
155 $42,000
Q2 2020

Aug 11, 2020

BUY
$225.48 - $295.8 $54,340 - $71,287
241 Added 354.41%
309 $90,000
Q1 2020

May 12, 2020

SELL
$199.77 - $247.81 $998 - $1,239
-5 Reduced 6.85%
68 $16,000
Q4 2019

Feb 11, 2020

BUY
$166.71 - $223.91 $12,169 - $16,345
73 New
73 $16,000
Q4 2018

Feb 13, 2019

SELL
$151.91 - $192.21 $446,615 - $565,097
-2,940 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$167.73 - $192.74 $14,760 - $16,961
-88 Reduced 2.91%
2,940 $567,000
Q2 2018

Aug 01, 2018

SELL
$145.72 - $169.96 $16,466 - $19,205
-113 Reduced 3.6%
3,028 $515,000
Q1 2018

May 16, 2018

SELL
$151.6 - $177.13 $2.13 Million - $2.49 Million
-14,041 Reduced 81.72%
3,141 $512,000
Q4 2017

Feb 13, 2018

BUY
$137.28 - $155.55 $2.35 Million - $2.67 Million
17,134 Added 35695.83%
17,182 $2.58 Million
Q3 2017

Nov 08, 2017

BUY
$148.13 - $162.24 $5,480 - $6,002
37 Added 336.36%
48 $7,000
Q2 2017

Aug 15, 2017

SELL
N/A
-62 Reduced 84.93%
11 $1,000
Q4 2016

Sep 15, 2017

SELL
N/A
-40 Reduced 35.4%
73 $5,000
Q3 2016

Sep 15, 2017

BUY
N/A
112 Added 11200.0%
113 $10,000
Q1 2016

Sep 15, 2017

SELL
N/A
-43 Reduced 97.73%
1 $0
Q4 2015

Sep 15, 2017

BUY
N/A
44
44 $6,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.